How Machine Learning is Helping Fight Drug-Resistant TB in Egypt

For over ten years, doctors in Egypt have been tracking how patients respond to tuberculosis treatment. Tuberculosis, a lung infection spread through the air, has always been hard to treat. But a bigger problem is growing: some TB strains no longer respond to standard medicines. These drug-resistant cases make up about 10% of all TB patients worldwide. Traditional tests often take weeks to confirm resistance, giving the disease time to spread. That’s where machine learning comes in.Researchers used ten years of patient records to train AI models. They looked for patterns in treatment history, symptoms, and lab results. The goal wasn’t just to predict resistance faster—it was to find hidden clues in patient data. Some factors, like past treatment failures or specific lab markers, turned out to be strong warning signs. The AI didn’t replace doctors but gave them a new tool to spot high-risk patients early. The study focused on Egypt, where TB rates are higher than in many developed countries. Limited healthcare resources mean every extra day counts. By spotting resistance sooner, doctors can switch to stronger medicines faster. The AI still needs testing in real-world clinics, but early results are promising. It shows how data science can tackle old health problems in new ways.